References
- Krchňák V, Zaoral M. Synthesis of [1-β-mercaptopropionic acid, 8-d-arginine]vasopressin (DDAVP) in solid phase. Simple optimalization. Collect Czech Chem Commun. 1979;44:1173–1178.
- Huguenin RL, Guttmann S. Synthase de l’Ala1-Ala6-Arg8-vasopressine et de l’Ala1-Ala6-Lys8-vasopressine, ainsi que de la (deamino-Ala)1-Ala6-Arg8-vasopressine et de la (desamino-Ala)1-Ala6-Lys8-vasopressine. Helv Chim Acta. 1965;48:1885–1898.
- Tuvemo T. DDAVP in childhood nocturnal enuresis. Acta Paediatr Scand. 1978;67:753–755.
- Hilton P, Stanton SL. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol. 1982;54:252–255.
- Mannucci PM, Ruggeri ZM, Pareti FI, et al. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977;1:869–872.
- Faerch M, Christensen JH, Corydon TJ, et al. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene. Clin Endocrinol (Oxf). 2008;68:395–403.
- Juul KV, Erichsen L, Robertson GL. Temporal delays and individual variation in antidiuretic response to desmopressin. Am J Physiol Renal Physiol. 2013;304:F268–F278.
- De Guchtenaere A, Van Herzeele C, Raes A, et al. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction. J Urol. 2011;185:2308–2313.
- Vande Walle JGJ, Bogaert GA, Mattsson S, et al. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int. 2006;97:603–609.
- Juul KV, Klein BM, Sandström R, et al. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol. 2011;300:F1116–F1122.
- Bie P, Sandgaard NC. Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1–10.
- Robertson GL, Mahr EA, Athar S, et al. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest. 1973;52:2340–2352.
- Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol. 2001;63:607–630.
- Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17:1820–1832.
- Stachenfeld NS, Taylor HS, Leone CA, et al. Oestrogen effects on urine concentrating response in young women. J Physiol (Lond). 2003;552:869–880.
- Perucca J, Bouby N, Valeix P, et al. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol. 2007;292:R700–R705.
- Hancock ML, Bichet DG, Eckert GJ, et al. Race, sex, and the regulation of urine osmolality: observations made during water deprivation. AJP Regul Integr Comp Physiol. 2010;299:R977–R980.
- Liu J, Sharma N, Zheng W, et al. Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis. AJP Ren Physiol. 2011;300:F433–F440.
- Vilhardt H, Lundin S. Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans. Gen Pharmacol. 1986;17:481–483.
- Robson WLM, Leung AKC, Norgaard JP. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol. 2007;178: 24–30.
- Vilhardt H, Lundin S, Falch J. Plasma kinetics of DDAVP in man. Acta Pharmacol Toxicol (Copenh). 1986;58:379–381.
- Rittig S, Schaumburg HL, Siggaard C, et al. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis. J Urol. 2008;179:2389–2395.
- Aikawa T, Kasahara T, Uchiyama M. Circadian variation of plasma arginine vasopressin concentration, or arginine vasopressin in enuresis. Scand J Urol Nephrol Suppl. 1999;202:47–49.
- Kamperis K, Rittig S, Jorgensen KA, et al. Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. AJP Ren Physiol. 2006;291: F1232–F1240.
- Dehoorne JL, Raes AM, van Laecke E, et al. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion. J Urol. 2006;176:749–753.